Cargando…
Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients
Stool testing based on tumour-derived markers might offer a promising approach for non-invasive colorectal cancer (CRC) screening. The aim of this study was to estimate the potential of a new test for faecal tumour M2-PK to discriminate patients with CRC from a large sample of unselected older adult...
Autores principales: | Haug, U, Rothenbacher, D, Wente, M N, Seiler, C M, Stegmaier, C, Brenner, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360192/ https://www.ncbi.nlm.nih.gov/pubmed/17406361 http://dx.doi.org/10.1038/sj.bjc.6603712 |
Ejemplares similares
-
Reply: New faecal tests for colorectal cancer screening: is tumour pyruvate kinase M2 one of the options?
por: Haug, U, et al.
Publicado: (2007) -
Reply: Faecal tumour pyruvate kinase M2: not a good marker for detection of colorectal adenomas
por: Haug, U, et al.
Publicado: (2008) -
Detection of Hypermethylated Spastic Paraplegia-20 in Stool Samples of Patients with Colorectal Cancer
por: Zhang, Hao, et al.
Publicado: (2013) -
Quantitative study of vimentin gene methylation in stool samples for colorectal cancer screening
por: Pakbaz, Behfar, et al.
Publicado: (2019) -
RAS Mutational Status Detection in Tissue, Plasma, and Stool Samples for Colorectal Cancer
por: Zhu, Liuying, et al.
Publicado: (2020)